Meropenem Bradex

Meropenem, the active ingredient in Meropenem Bradex, is a carbapenem antibiotic presented as a sterile powder for intravenous use. It provides broad‑spectrum antibacterial activity for severe infections in adult and pediatric patients.

GNH USA supplies Meropenem Bradex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

Meropenem is used to treat serious infections caused by susceptible bacteria across several organ systems.

- Complicated intra‑abdominal infections: provides broad‑spectrum coverage against Gram‑negative, Gram‑positive and anaerobic organisms, helping to resolve infection. - Complicated urinary tract infections: eradicates resistant uropathogens, facilitating clinical cure. - Bacterial meningitis: penetrates the cerebrospinal fluid to achieve bactericidal activity against common meningitis pathogens. - Hospital‑acquired pneumonia including ventilator‑associated pneumonia: offers potent activity against multidrug‑resistant Gram‑negative bacteria. - Skin and soft‑tissue infections (including diabetic foot): delivers rapid bacterial killing to improve healing.

Adverse reactions to Meropenem can vary from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea: mild gastrointestinal upset occurring in many patients. - Diarrhea: may be watery and self‑limiting. - Rash: mild skin erythema or pruritus. - Headache: transient headache reported during treatment.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Clostridioides difficile‑associated colitis: severe diarrhea due to overgrowth of toxin‑producing bacteria. - Anaphylaxis: acute, potentially life‑threatening hypersensitivity reaction. - Renal toxicity: elevated creatinine or acute kidney injury in susceptible individuals.

When prescribing Meropenem, clinicians should consider several safety precautions to minimize risk.

- Renal impairment: adjust dose based on creatinine clearance. - History of seizures: use with caution as the drug can lower seizure threshold. - Hypersensitivity: avoid in patients with known allergy to β‑lactams. - Pediatric use: dose must be calculated per kilogram body weight. - Concomitant valproic acid therapy: monitor for decreased valproate levels and possible breakthrough seizures. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Valproic acid: carbapenems reduce serum valproate concentrations, increasing seizure risk. - Probenecid: may increase meropenem plasma levels, raising toxicity potential. - Aminoglycosides (e.g., gentamicin): combined nephrotoxic effect; monitor renal function closely.

Moderate Interactions (Monitor Closely): - Loop diuretics (e.g., furosemide): additive renal stress, watch creatinine. - Anticoagulants (e.g., warfarin): possible alteration of INR, check coagulation parameters. - Oral contraceptives: theoretical reduction in efficacy; advise backup contraception.